GlassScriptPhysician profile
Rita L Forhan
NPI 1912937236
$4,312.17
in general payments reported to CMS, 2019-2025
16 companies · $1,615 in 2025
The $1,615 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $442 · 2022: $778 · 2023: $223 · 2024: $1,255 · 2025: $1,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,092.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,088.00 | 2024-2025 | |
| Gilead Sciences, INC. | $806.90 | 2022-2025 | Livdelzi, Epclusa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $428.67 | 2021-2024 | Xifaxan |
| Madrigal Pharmaceuticals | $375.78 | 2024-2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $291.05 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $241.03 | 2021-2024 | Gattex |
| Boston Scientific Corporation | $156.53 | 2024-2025 | Watchman Flx |
| Ardelyx, INC. | $136.59 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $121.83 | 2025 | |
| Ferring Pharmaceuticals INC. | $120.51 | 2023 | Rebyota |
| Nestle Healthcare Nutrition INC. | $118.67 | 2021 | |
| Mallinckrodt Hospital Products INC. | $117.19 | 2025 | Acthar |
| Janssen Biotech, INC. | $106.49 | 2025 | Tremfya |
| Intercept Pharmaceuticals, INC. | $104.70 | 2022 | |
| Aimmune Therapeutics, INC. | $80.80 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $17.43 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Forhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.